Ketamine – The Game Changer for Depression Treatment | Northern Virginia Ketamine Therapy | 22306

NOVA Health Recovery Ketamine Infusion Center – Alexandria, Virginia

Feel free to contact us for more information or to schedule an interview:

Security Code:
security code
Please enter the security code:

Submit

Depressed? Anxious? Does the change of seasons make this worse for you? Have you been unable to feel motivated about work or your favorite hobbies? Has the pandemic affected your family with loss or closed your usual outlets for stress relief such as the gym or travel?  Over 4% of the population suffers from depression every year, and along with it comes low energy, sadness, fatigue, and even a predisposition to general illnesses such as strokes and heart attacks. Loss of sleep or excess sleep as well as significant appetite changes are a part of this. This year will probably be worse for mental health due to the current world situation.   

Many people have anxiety that runs hand in hand with the gloomy despair of worsening depression. Traditional antidepressants are frequently used, but many times they take a long time to work or don’t work at all. In the meantime, your job, family life, and personal life suffer as various medications are tried sequentially. Depression has been shown to alter the ability of connections within the brain to form or maintain appropriately, a process called neuroplasticity. A depressed person can have areas of the brain that shrink due to loss of neural connections, such as the memory centers and the front part of the brain that is involved in decision making, motivation, and reward. This results in brain fog and poor decision-making. 

Ketamine therapy offers a rapid solution to treat mood disorders within days in over 70% of treatment resistant patients. Ketamine has been used safely for over 50 years. Numerous studies have consistently shown its rapid, beneficial effects in depression and suicidality. It has also been effective in OCD, anxiety, PTSD, bipolar depression, post-partum depression, addictions, and pain.  This is due to the neuroplasticity that ketamine produces and improvement of the reward mechanisms of the brain. Anyone with depression or anxiety may be a candidate for this therapy, and especially when waiting 6 weeks or more to see if your new medication will work isn’t an option, the possibility of receiving ketamine therapy should be considered. Schizophrenia, personality disorders, and active heart diseases are among the disqualifiers for this treatment. 

Ketamine is given through a series of 6 or more infusions scattered over 2-3 weeks in a monitored office setting. Periodic follow-up infusions may be needed for some. This medication has been a game changer for many patients who have suffered for years. Frequently vitamins or NAD+ can be added to the infusion process to improve energy levels and dissolve fatigue. In the meantime, other traditional and integrative treatments should be incorporated, such as exercise, intermittent fasting, low carbohydrate diets, supplements, and sleep hygiene. If you are looking for more information for this treatment, look to webmd.com for a local provider or more information. Also you can reach out to NOVA Health Recovery in Alexandria, Virginia for more information or to schedule.

REVISITING THE HALLUCINOGENIC POTENTIAL OF KETAMINE 

WE NOW KNOW WHY KETAMINE IS SO EFFECTIVE AT TREATING DEPRESSION 

FIRST KETAMINE INFUSION CLINIC IN PALM SPRINGS, CA OPENS 

FROM CHAOS TO CALM: A LIFE CHANGED BY KETAMINE 

IS KETAMINE THE NEXT BIG DEPRESSION DRUG? 

KETAMINE RELIEVES DEPRESSION BY RESTORING BRAIN CONNECTIONS 

IS KETAMINE THE BEST HOPE FOR CURING MAJOR DEPRESSION? 

KETAMINE DEPRESSION TREATMENT ‘SHOULD BE ROLLED OUT’ 

KETAMINE: THE FUTURE OF DEPRESSION TREATMENT? 

ONCE IT FULLY CATCHES ON, KETAMINE COULD BE A REALLY IMPORTANT ANTIDEPRESSANT 

TACKLING DEPRESSION WITH KETAMINE 

ONETIME PARTY DRUG HAILED AS MIRACLE FOR TREATING SEVERE DEPRESSION 

YALE SCIENTISTS EXPLAIN HOW KETAMINE VANQUISHES DEPRESSION WITHIN HOURS 

WHAT IT’S LIKE TO HAVE YOUR SEVERE DEPRESSION TREATED WITH A HALLUCINOGENIC DRUG 

KETAMINE INFUSIONS CUT MIGRAINE PAIN IN HALF IN NEW STUDY 

FOR RECALCITRANT NEUROPATHIC PAIN, CONSIDER OUTPATIENT KETAMINE 

KETAMINE RESETS SYSTEM FOR NORMAL PAIN PROCESSING IN COMPLEX SYNDROME PATIENTS 

FIBROMYALGIA DOCTOR TOUTS KETAMINE FOR PAIN AND DEPRESSION 

FIBROMYALGIA PATIENTS TREATED WITH INTRAVENOUS KETAMINE 

THIS COULD BE BIG: INTRAVENOUS KETAMINE FOR FIBROMYALGIA 

THE CURRENT MENTAL HEALTH CRISIS AND THE COMING KETAMINE REVOLUTION 

YALE: ‘MAGIC’ ANTIDEPRESSANT MAY HOLD PROMISE FOR PTSD 

IV KETAMINE RAPIDLY EFFECTIVE IN PTSD 

KETAMINE MAY HELP EXTINGUISH FEARFUL MEMORIES 

KETAMINE COULD PROVE USEFUL IN TREATMENT OF SEVERE SOCIAL ANXIETY 

PSYCHEDELIC MEDICINE 101: THE CURIOUS CASE OF KETAMINE 

Links to Academic Articles 

RAPID AND LONGER-TERM ANTIDEPRESSANT EFFECTS OF REPEATED KETAMINE INFUSIONS IN TREATMENT-RESISTANT MAJOR DEPRESSION 

SAFETY AND EFFICACY OF REPEATED-DOSE INTRAVENOUS KETAMINE FOR TREATMENT-RESISTANT DEPRESSION 

NEUROBIOLOGY OF STRESS, DEPRESSION, AND RAPID ACTING ANTIDEPRESSANTS: REMODELING SYNAPTIC CONNECTIONS 

NEW PARADIGMS FOR TREATMENT-RESISTANT DEPRESSION 

ANTIDEPRESSANT EFFICACY OF KETAMINE IN TREATMENT-RESISTANT MAJOR DEPRESSION: A TWO-SITE RANDOMIZED CONTROLLED TRIAL 

HIPPOCAMPAL VOLUME AND THE RAPID ANTIDEPRESSANT EFFECT OF KETAMINE 

KETAMINE AND THE NEXT GENERATION OF ANTIDEPRESSANTS WITH A RAPID ONSET OF ACTION 

DO THE DISSOCIATIVE SIDE EFFECTS OF KETAMINE MEDIATE ITS ANTIDEPRESSANT EFFECTS? 

SYMPTOMATOLOGY AND PREDICTORS OF ANTIDEPRESSANT EFFICACY IN EXTENDED RESPONDERS TO A SINGLE KETAMINE INFUSION. 

ANTIDEPRESSANT EFFECTS OF KETAMINE IN DEPRESSED PATIENTS 

THE ROLE OF KETAMINE IN TREATMENT-RESISTANT DEPRESSION: A SYSTEMATIC REVIEW 

IMPROVEMENT IN SUICIDAL IDEATION AFTER KETAMINE INFUSION: RELATIONSHIP TO REDUCTIONS IN DEPRESSION AND ANXIETY 

USE OF KETAMINE IN ACUTE CASES OF SUICIDALITY 

A POSSIBLE ROLE FOR KETAMINE IN SUICIDE PREVENTION IN EMERGENCY AND MAINSTREAM PSYCHIATRY 

EFFICACY OF INTRAVENOUS KETAMINE FOR TREATMENT OF CHRONIC POST-TRAUMATIC STRESS DISORDER: A RANDOMIZED CLINICAL TRIAL 

EFFICACY OF KETAMINE IN THE TREATMENT OF SUBSTANCE USE DISORDERS: A SYSTEMATIC REVIEW 

KETAMINE REDUCES MUSCLE PAIN, TEMPORAL SUMMATION, AND REFERRED PAIN IN FIBROMYALGIA PATIENTS 

KETAMINE IN CHRONIC PAIN MANAGEMENT: AN EVIDENCE-BASED REVIEW 

RANDOMIZED CONTROLLED CROSSOVER TRIAL OF KETAMINE IN OBSESSIVE-COMPULSIVE DISORDER: PROOF-OF-CONCEPT 

RAPID RESOLUTION OF OBSESSIONS AFTER AN INFUSION OF INTRAVENOUS KETAMINE IN A PATIENT WITH TREATMENT-RESISTANT OBSESSIVE-COMPULSIVE DISORDER: A CASE REPORT 

ANALGESIC EFFECT OF SUBANESTHETIC INTRAVENOUS KETAMINE IN REFRACTORY NEUROPATHIC PAIN: A CASE REPORT 

PAIN ANALYSIS IN PATIENTS WITH FIBROMYALGIA. EFFECTS OF INTRAVENOUS MORPHINE, LIDOCAINE, AND KETAMINE 

KETAMINE FOR SOCIAL ANXIETY DISORDER: A RANDOMIZED, PLACEBO-CONTROLLED CROSSOVER TRIAL 

NOVEL TREATMENT FOR LEVODOPA INDUCED MOTOR FLUCTUATIONS AND DYSKINESIA ASSOCIATED WITH PARKINSON’S DISEASE 

KLEINE LEVIN SYNDROME (KLS) RESEARCH UPDATE IN LABORATORY OF DR. MIGNOT, STANFORD UNIVERSITY 

Leave a Reply

Your email address will not be published. Required fields are marked *